Kenvue Income After Taxes 2020-2024 | KVUE
Kenvue annual/quarterly income after taxes history and growth rate from 2020 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Kenvue income after taxes for the quarter ending June 30, 2024 was $0.058B, a 86.51% decline year-over-year.
- Kenvue income after taxes for the twelve months ending June 30, 2024 was $1.119B, a 38.89% decline year-over-year.
- Kenvue annual income after taxes for 2023 was $1.664B, a 19.38% decline from 2022.
- Kenvue annual income after taxes for 2022 was $2.064B, a 0.67% decline from 2021.
- Kenvue annual income after taxes for 2021 was $2.078B, a 336.41% decline from 2020.
Kenvue Annual Income After Taxes (Millions of US $) |
2023 |
$1,664 |
2022 |
$2,064 |
2021 |
$2,078 |
2020 |
$-879 |
2019 |
$1,435 |
Kenvue Quarterly Income After Taxes (Millions of US $) |
2024-06-30 |
$58 |
2024-03-31 |
$296 |
2023-12-31 |
$327 |
2023-09-30 |
$438 |
2023-06-30 |
$430 |
2023-03-31 |
$469 |
2022-12-31 |
$346 |
2022-09-30 |
$586 |
2022-06-30 |
$604 |
2022-03-31 |
$528 |
2021-12-31 |
|
2020-12-31 |
|
2019-12-31 |
|
Sector |
Industry |
Market Cap |
Revenue |
Consumer Staples |
Consumer Products - Misc. Discretionary |
$44.413B |
$15.444B |
Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J.
|